| Year |
Citation |
Score |
| 2008 |
Chen N, Aleksa K, Woodland C, Rieder M, Koren G. N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. British Journal of Pharmacology. 153: 1364-72. PMID 18278066 DOI: 10.1038/Bjp.2008.15 |
0.686 |
|
| 2007 |
Chen N, Aleksa K, Woodland C, Rieder M, Koren G. Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations. The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique. 14: e246-50. PMID 17652768 |
0.652 |
|
| 2007 |
Chen N, Aleksa K, Woodland C, Rieder M, Koren G. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells. Translational Research : the Journal of Laboratory and Clinical Medicine. 150: 51-7. PMID 17585863 DOI: 10.1016/J.Trsl.2007.02.001 |
0.691 |
|
| 2006 |
Chen N, Aleksa K, Woodland C, Rieder M, Koren G. Ontogeny of drug elimination by the human kidney. Pediatric Nephrology (Berlin, Germany). 21: 160-8. PMID 16331517 DOI: 10.1007/S00467-005-2105-4 |
0.674 |
|
| 2005 |
Pinto N, Halachmi N, Verjee Z, Woodland C, Klein J, Koren G. Ontogeny of renal P-glycoprotein expression in mice: correlation with digoxin renal clearance. Pediatric Research. 58: 1284-9. PMID 16306209 DOI: 10.1203/01.Pdr.0000188697.99079.27 |
0.494 |
|
| 2005 |
KALRA S, KLEIN J, KARASKOV T, WOODLAND C, EINARSON A, KOREN G. Use of hair cortisol as a biomarker for chronic stress in pregnancy Clinical Pharmacology & Therapeutics. 77: P69-P69. DOI: 10.1016/J.Clpt.2004.12.155 |
0.324 |
|
| 2004 |
Woodland C, Koren G, Wainer IW, Batist G, Ito S. Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents. Canadian Journal of Physiology and Pharmacology. 81: 800-5. PMID 12897809 DOI: 10.1139/Y03-073 |
0.466 |
|
| 2003 |
Woodland C, Koren G, Ito S. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example. Journal of Clinical Pharmacology. 43: 743-50. PMID 12856388 |
0.51 |
|
| 2003 |
Woodland C, Koren G, Ito S. From Bench to Bedside: Utilization of an In Vitro Model to Predict Potential Drug-Drug Interactions in the Kidney: The Digoxin-Mifepristone Example The Journal of Clinical Pharmacology. 43: 743-750. DOI: 10.1177/0091270003254800 |
0.562 |
|
| 2002 |
Aleksa K, Woodland C, Koren G. Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies. Pediatric Nephrology (Berlin, Germany). 16: 1153-8. PMID 11793120 DOI: 10.1007/S004670100053 |
0.682 |
|
| 2001 |
Woodland C, Ito S, Granvil CP, Wainer IW, Klein J, Koren G. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. Life Sciences. 68: 109-17. PMID 11132240 DOI: 10.1016/S0024-3205(00)00915-2 |
0.596 |
|
| 2001 |
Boskovic R, Klein J, Woodland C, Karaskov T, Koren G. The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: A twin study Canadian Journal of Physiology and Pharmacology. 79: 942-945. DOI: 10.1139/Y01-080 |
0.377 |
|
| 1999 |
Ito S, Woodland C, Sarkadi B, Hockmann G, Walker SE, Koren G. Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. The American Journal of Physiology. 277: F84-96. PMID 10409301 DOI: 10.1152/Ajprenal.1999.277.1.F84 |
0.435 |
|
| 1998 |
Woodland C, Ito S, Koren G. A model for the prediction of digoxin-drug interactions at the renal tubular cell level. Therapeutic Drug Monitoring. 20: 134-8. PMID 9558126 DOI: 10.1097/00007691-199804000-00002 |
0.522 |
|
| 1994 |
Ito S, Woodland C, Harper PA, Koren G. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). Life Sciences. 53: PL399-403. PMID 8246676 DOI: 10.1016/0024-3205(93)90495-O |
0.538 |
|
| 1993 |
Ito S, Woodland C, Harper PA, Koren G. P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model. Life Sciences. 53: PL25-31. PMID 8100040 DOI: 10.1016/0024-3205(93)90667-R |
0.535 |
|
| 1993 |
Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Hom M, Koren G. Pregnancy Outcome Following First-Trimester Exposure to Fluoxetine (Prozac) Obstetrical & Gynecological Survey. 48: 656-657. DOI: 10.1001/Jama.1993.03500170076037 |
0.36 |
|
| Show low-probability matches. |